Peter T. Slover
Equibles does not estimate personal net worth.
Get an email with a short summary when Contineum Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CTNM alertsAbout Peter T. Slover
Peter T. Slover is recorded as CFO at Contineum Therapeutics, Inc. (CTNM). The newest filing on record that lists Peter T. Slover as CFO at Contineum Therapeutics, Inc. (CTNM) is dated April 30, 2026. The proxy statement of Contineum Therapeutics, Inc. reports total compensation of $1,577,903 for Peter T. Slover in fiscal 2025, including a base salary of $487,487. Contineum Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Contineum Therapeutics, Inc. includes Carmine N. Stengone (CEO and Board Member), John S. Healy (General Counsel), Diego Miralles (Board Member) and 6 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 30, 2026
Company network
Leadership on record at Contineum Therapeutics, Inc.
- Carmine N. Stengone CEO, Board Member
- John S. Healy General Counsel
- Diego Miralles Board Member
- Diego Miralles, M.D. Board Member
- Lori M. Lyons-Williams Board Member
- Olivia Ware Board Member
- Sarah Boyce Board Member
- Todd Brady Board Member
- Troy Ignelzi Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Contineum Therapeutics, Inc. (CTNM) | Chief Financial Officer | $487,487 | $1,577,903 |
Recent activity
No call appearances or filed executive changes recorded yet.